CervoMed Inc.
CRVO
$9.49
$0.060.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -19.44% | 15.14% | 36.29% | 116.29% | 208.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.44% | 15.14% | 36.29% | 116.29% | 208.63% |
| Cost of Revenue | 97.25% | 179.07% | 190.09% | 263.68% | 341.49% |
| Gross Profit | -810.08% | -1,947.79% | -1,463.07% | -793.67% | -370.91% |
| SG&A Expenses | 11.02% | 23.22% | 40.61% | 80.71% | 193.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.50% | 77.22% | 86.96% | 115.40% | 167.42% |
| Operating Income | -128.52% | -133.09% | -133.29% | -114.74% | -138.78% |
| Income Before Tax | -348.36% | -349.69% | -650.10% | -793.71% | -15.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -348.36% | -349.69% | -650.10% | -793.71% | -15.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -348.36% | -349.69% | -650.10% | -793.71% | -15.41% |
| EBIT | -128.52% | -133.09% | -133.29% | -114.74% | -138.78% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -543.67% | 25.67% | 43.29% | 73.74% | 95.25% |
| Normalized Basic EPS | -543.45% | 25.67% | 43.29% | 73.74% | 95.25% |
| EPS Diluted | -47.68% | 49.24% | 58.95% | 78.45% | 79.27% |
| Normalized Diluted EPS | -437.42% | 27.65% | 44.54% | 74.08% | 94.31% |
| Average Basic Shares Outstanding | 43.40% | 114.02% | 204.13% | 513.80% | 1,079.89% |
| Average Diluted Shares Outstanding | 40.76% | 108.16% | 191.54% | 460.92% | 1,102.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |